Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease

Mesenchymal stromal cells (MSCs) offer great potential for the treatment of cardiovascular diseases (CVDs) such as myocardial infarction and heart failure. Studies have revealed that the efficacy of MSCs is mainly attributed to their capacity to secrete numerous trophic factors that promote angiogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazari‐Shafti, Timo Z., Neuber, Sebastian, Garcia Duran, Ana, Xu, Zhiyi, Beltsios, Eleftherios, Seifert, Martina, Falk, Volkmar, Stamm, Christof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Concise Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695640/
https://www.ncbi.nlm.nih.gov/pubmed/32761804
http://dx.doi.org/10.1002/sctm.19-0432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695640/
https://www.ncbi.nlm.nih.gov/pubmed/32761804
http://dx.doi.org/10.1002/sctm.19-0432

Ejemplares similares